Obesity and heart failure

Journal of Cardiovascular Nursing

Volumn 18, Issue 5, 2003, Pages 360-368

  Coviello, Jessica S ^a   Nyström, Karin V ^a  

^a YALE UNIVERSITY   (United States)

Author keywords

Body mass index; Cardiac risk factors; Heart failure; Inflammatory markers; Obesity

Indexed keywords

BODY MASS; CONGESTIVE HEART FAILURE; HUMAN; OBESITY; PATHOPHYSIOLOGY; REVIEW; RISK FACTOR; UNITED STATES;

BODY MASS INDEX; HEART FAILURE, CONGESTIVE; HUMANS; OBESITY; RISK FACTORS; UNITED STATES;

EID: 0642287899     PISSN: 08894655     EISSN: 15505049     Source Type: Journal    
DOI: 10.1097/00005082-200311000-00007     Document Type: Article

References (48)

1. Hubert HB, Feinleib M, McNamara PM, Castelli WP. Obesity as an independent risk factor for cardiovascular diseases: a 26-year follow-up of participants in the Framingham Heart Study. Circulation. 1983;67:968-977.
2. Davos CH, Doehner W, Rauchhaus M, et al. Obesity and survival in chronic heart failure. Circulation. 2000;102:(suppl II):II-876.
3. AHA Top 10 research advances for 2002. Available at:. Accessed 2003.
4. Kenchaiah S, Evans JC, Levy D, et al. Obesity and the risk of heart failure. N Engl J Med. 2002;347:303-313.
5. International Obesity Task Force. Available at:. Accessed 2003.
6. World Health Organization. Obesity: Preventing and managing the global epidemic. Report of a WHO Consultation on Obesity. Geneva: World Health Organization; 1997.
7. Eckel RH. Obesity and heart disease: a statement for health-care professionals from the nutrition committee, American Heart Association. Circulation. 1997;96:3248-3250.
8. Kuczmarski RJ, Flegal KM, Campbell SM, Johnson CL. Increasing prevalence of overweight among U.S. adults: the National Health and Nutrition Examination Survey. JAMA. 1994;272:205-211.
9. Hill JO, Wyatt HR, Reed GW, Peters JC. Obesity and the environment: where do we go from here? Science. 2003; 299:853-855.
10. Rossner S. Obesity: the disease of the twenty-first century. Int J Obes. 2002;26:S2-S4.
11. Jeffrey R, French S. Epidemic obesity in the United States: are fast foods and television viewing contributing? Am J Public Health. 1998;88(2):277-280.
12. Wolf AM, Colditz GA. Currrent estimates of the economic costs of obesity in the United States. Obes Res. 1998;6: 97-106.
13. American Heart Association. Heart and Stroke Statisticals— 2003 Update. Dallas, Tex: American Heart Association; 2002.
14. He J, Ogden LG, Bazzano LA, et al. Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study. Arch Intern Med. 2001;161:996-1002.
15. Chen YT, Vaccarino V, Williams CS, et al. Risk factors for heart failure in the elderly; a prospective community-based study. Am J Med. 1999;106:605-612.
16. Wilhelmsen L, Rosengren A, Eriksson H, Lappas G. Heart failure in the general population of men—morbidity, risk factors, and prognosis. J Intern Med. 2001;249: 253-261.
17. Alpert MA, Lambert CR, Terry BE, et al. Influence of left ventricular diastolic filling in normotensive morbid obesity. Am Heart J. 1995;130:1068-1073.
18. Messerli FH, Sundgaard-Risse K, Reisin ED, et al. Dimorphic cardiac adaptation to obesity and arterial hypertension. Ann Intern Med. 1983;99:757-761.
19. Hammond IW, Devereux RB, Alderman MH, Laragh JH. Relation of blood pressure and body build to left ventricular mass in normotensive and hypertensive employed adults. J Am Coll Cardiol. 1988;12:996-1004.
20. Lauer MS, Anderson KM, Kannel WB, Levy D. The impact of obesity on left ventricular mass and geometry: the Framingham Heart Study. JAMA. 1991;266:231-236.
21. Alexander JK, Dennis EW, Smith WG, Amad KH, Duncan WC, Austin RC. Blood volume, cardiac output, and distribution of systemic blood flow in extreme obesity. Cardiovasc Res Cent Bull. 1963;1:39-44.
22. Engeli S, Sharma AM. The renin-angiotensin system and natriuretic peptides in obesity-associated hypertension. J Mol Med. 2001;74:21-29.
23. Vincent HK, Powers SK, Stewart DJ, et al. Obesity is associated with increased myocardial oxidative stress. Int J Obes Relat Metab Disord. 1999;23:67-74.
24. Young ME, Guthrie PH, Razeghi P, et al. Impaired long-chain fatty acid oxidation and contractile dysfunction in the obese Zucker rat heart. Diabetes. 2002;51:2587-2595.
25. Schunkert H. Obesity and target organ damage. Int J Obes. 2002;26:515-520.
26. Thakur V, Richards R, Reisin E. Obesity, hypertension and the heart. Am J Med Sci. 2001;321:242-248.
27. Must A, Spadano J, Coakley EH, et al. The disease burden associated with overweight and obesity. JAMA. 1999;282:1523-1529.
28. Hans TS, Van Leer EM, Seidell JL, Lean ME. Waist circumference action level in the idenitification of cardiovascular risk factors; prevalence study in a random sample. BMJ. 1995;311:1401-1405.
29. DeFronzo RA, Ferrannini E. Insulin resistance: a multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease. Diabetes Care. 1991;14:173-194.
30. Bell DS. Beta-blockers in the diabetic patient. Pract Diabetol. March 2003;20-23.
31. Ford ES, Giles WH. Metabolic syndrome among US adults: findings from the third national health and nutrition examination survey. JAMA. 2002;287:356-359.
32. Hall JE. Mechanisms of normal renal sodium handling in obesity and hypertension. Am J Hypertens. 1997;10(pt 2): 495-555.
33. Luft FC, Weinberger MH. Heterogeneous responses to changes in dietary salt intake; the salt sensitivity paradigm. Am J Clin Nutr. 1997;65(suppl): 6125-6175.
34. Rocchini AP, Key S, Bondie D, et al. The effect of weight loss on the sensitivity of blood pressure and sodium in obese adolescents. N Engl J Med. 1989;321:580-585.
35. Executive Summary of the Third Report of the National Cholesterol Education Program (NECP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. (Adult Treatment Panel III). JAMA. 285:2486-2497.
36. Rao SV, Donahue M, Pi-Sunyer FX, Fuster V. Obesity as a risk factor in coronary artery disease. Am Heart J. 2001; 142:1102-1107.
37. Grimble RF. Inflammatory status and insulin resistance. Curr Opin Clin Nutr Metab. 2002;5:551-559.
38. Ridker PM, Cushman MN, Stampfer RP, et al. Inflammation aspirin and the risk of cardiovascular disease in apparently healthy men. N Engl J Med. 1997;336: 973-979.
39. Ridker PM, Hennekens CH, Buring JE, Rifai N. C-reactive protein and other markers of inflammation in the prediction of cardiovascular disease in women. N Engl J Med. 2000;342:836-843.
40. Yudkin JS, Kumari M, Humphries S, Mohamed Ali V. Inflammation, obesity, stress, and coronary heart disease: is interleukin-6 the link? Atherosclerosis. 2000;148:209-214.
41. Rogge MM. The case for an immunologic cause of obesity. Biol Res Nurs. 2002;4:43-45.
42. Chan JC, Cheung JC, Stehouwer CD, et al. The central roles of obesity-associated dyslipidemia, endothelial activation and cytokines in the metabolic syndrome—an analysis by structural equation modeling. Int J Obes Relat Metab Dis: J Int Assoc Study Obes. 2002;26:994-1008.
43. Lee MD, Kim IC. Hypothesis: is obesity an inflammatory condition? Comment Nutr. 2001;17:953-966.
44. Eckel RH, Barouch WW, Ershow AG. Report of the National Heart, Lung, and Blood Institute—National Institute of Diabetes and Digestive and Kidney Diseases Working Group on the Pathophysiology of Obesity-Associated Cardiovascular Disease. Circulation. 2002; 105:2923-2928.
45. National Institutes of Health, National Heart, Lung and Blood Institute. Clinical Guidelines on the Identification, Evaluation and Treatment of Overweight and Obesity in Adults. Bethesda, Md: NIH; September 1998. NIH Publication No. 98-4083.
46. Klem ML, Wing RR, McGuire MT, et al. A descriptive study of individuals successful at long-term maintenance of substantial weight loss. Am J Clin Nutr. 1997;66:239-246.
47. Pi-Sunyer FX. A clinical view of the obesity problem. Science. 2003;299:859-860.
48. Glenny AM, O'Meara S, Melville A, Shelson TA, Wilson C. The treatment and prevention of obesity: a systematic review of the literature. Int J Obes. 1997;21: 715-737.